146 related articles for article (PubMed ID: 15935302)
1. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
2. Advances in pre- and posttransplant immunologic testing in kidney transplantation.
Süsal C; Pelzl S; Simon T; Opelz G
Transplant Proc; 2004; 36(1):29-34. PubMed ID: 15013292
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection.
Pelzl S; Opelz G; Daniel V; Wiesel M; Süsal C
Transplantation; 2003 Feb; 75(3):421-3. PubMed ID: 12589170
[TBL] [Abstract][Full Text] [Related]
4. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
Cinti P; Pretagostini R; Arpino A; Tamburro ML; Mengasini S; Lattanzi R; De Simone P; Berloco P; Molajoni ER
Transplantation; 2005 Mar; 79(5):599-601. PubMed ID: 15753850
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E
Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845
[TBL] [Abstract][Full Text] [Related]
7. Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30.
Süsal C; Pelzl S; Opelz G
Transplantation; 2003 Oct; 76(8):1231-2. PubMed ID: 14578759
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
Mehta R; Shah G; Adler W; Kittur D
Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation.
Fitzgerald JT; Johnson JR; Perez RV
Clin Transplant; 2004 Aug; 18(4):434-9. PubMed ID: 15233822
[TBL] [Abstract][Full Text] [Related]
11. Influence of panel-reactive antibody on survival and rejection after lung transplantation.
Gammie JS; Pham SM; Colson YL; Kawai A; Keenan RJ; Weyant RJ; Griffith BP
J Heart Lung Transplant; 1997 Apr; 16(4):408-15. PubMed ID: 9154951
[TBL] [Abstract][Full Text] [Related]
12. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
Reinsmoen NL; Nelson K; Zeevi A
Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
[TBL] [Abstract][Full Text] [Related]
13. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates.
Ozdemir FN; Sezer S; Akcay A; Arat Z; Turan M; Gulmus S; Kulah E; Haberal M
Transpl Immunol; 2004 Jan; 12(2):185-8. PubMed ID: 14967317
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic monitoring of serum soluble HLA class I antigens in renal transplant recipients].
Xu J; Cao Q; Wu D; Ma J; Yu L
Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):657-9. PubMed ID: 11829918
[TBL] [Abstract][Full Text] [Related]
15. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation.
Petrossian GA; Nichols AB; Marboe CC; Sciacca R; Rose EA; Smith CR; Cannon PJ; Reemtsma K; Powers ER
Circulation; 1989 Nov; 80(5 Pt 2):III122-5. PubMed ID: 2805291
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to HLA class II antigens as a risk factor for acute rejection of the allogeneic kindey.
Slavcev A; Lacha J; Sajdlova H; Vitko S; Valhova S; Striz I; Ivaskova E
Ann Transplant; 2004; 9(3):44-7. PubMed ID: 15759547
[TBL] [Abstract][Full Text] [Related]
17. Anti-HLA antibodies in heart transplantation.
Vasilescu ER; Ho EK; de la Torre L; Itescu S; Marboe C; Cortesini R; Suciu-Foca N; Mancini D
Transpl Immunol; 2004 Jan; 12(2):177-83. PubMed ID: 14967316
[TBL] [Abstract][Full Text] [Related]
18. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.
Tinckam KJ; Wood IG; Ji F; Milford EL
Hum Immunol; 2004 Nov; 65(11):1281-7. PubMed ID: 15556678
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.
Hoffman JA; Weinberg KI; Azen CG; Horn MV; Dukes L; Starnes VA; Woo MS
Transpl Infect Dis; 2004 Dec; 6(4):147-55. PubMed ID: 15762932
[TBL] [Abstract][Full Text] [Related]
20. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant.
Piazza A; Torlone N; Valeri M; Poggi E; Monaco PI; Provenzani L; Tisone G; Adorno D; Casciani CU
Transplant Proc; 1993 Dec; 25(6):3279-80. PubMed ID: 8266542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
